Paper36979155
FGFR2c Upregulation Contributes to Cancer-Associated Fibroblast Program Activation and to Enhanced Autophagy in Actinic Keratosis-Derived Dermal Fibroblasts: A Possible Role in Precancerous Cell/Stromal Cell Crosstalk.
Guttieri L and 8 others. Biology (Basel), 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. FGFR2c Upregulation Contributes to Cancer-Associated Fibroblast Program Activation and to Enhanced Autophagy in Actinic Keratosis-Derived Dermal Fibroblasts: A Possible Role in Precancerous Cell/Stromal Cell Crosstalk. Papers, record 36979155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979155
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
FGFR2c Upregulation Contributes to Cancer-Associated Fibroblast Program Activation and to Enhanced Autophagy in Actinic Keratosis-Derived Dermal Fibroblasts: A Possible Role in Precancerous Cell/Stromal Cell Crosstalk.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PRIN 2017-Prot. 20174TB8KW | Ministero dell'Istruzione dell'Università e della Ricerca | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17458890 | AKT and MAPK signaling in KGF-treated and UVB-exposed human epidermal cells. | J Cell Physiol | 2007 | https://conductscience.org/library/papers/17458890 | PubMed |
| 2 | 22682238 | Field cancerization: something new under the sun. | Cell | 2012 | https://conductscience.org/library/papers/22682238 | PubMed |
| 3 | 33920760 | Expression Profile of Fibroblast Growth Factor Receptors, Keratinocyte Differentiation Markers, and Epithelial Mesenchymal Transition-Related Genes in Actinic Keratosis: A Possible Predictive Factor for Malignant Progression? | Biology (Basel) | 2021 | https://conductscience.org/library/papers/33920760 | PubMed |
| 4 | 25450802 | HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25450802 | PubMed |
| 5 | 27500794 | Current perspective on actinic keratosis: a review. | Br J Dermatol | 2017 | https://conductscience.org/library/papers/27500794 | PubMed |
| 6 | 26274903 | Grading keratinocyte atypia in actinic keratosis: a correlation of reflectance confocal microscopy and histopathology. | J Eur Acad Dermatol Venereol | 2015 | https://conductscience.org/library/papers/26274903 | PubMed |
| 7 | 17488400 | Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. | Br J Dermatol | 2007 | https://conductscience.org/library/papers/17488400 | PubMed |
| 8 | 10607351 | Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). | J Am Acad Dermatol | 2000 | https://conductscience.org/library/papers/10607351 | PubMed |
| 9 | 28877478 | The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI. | Cell Rep | 2017 | https://conductscience.org/library/papers/28877478 | PubMed |
| 10 | 22708584 | Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. | BMC Bioinformatics | 2012 | https://conductscience.org/library/papers/22708584 | PubMed |
| 11 | 31980749 | A framework for advancing our understanding of cancer-associated fibroblasts. | Nat Rev Cancer | 2020 | https://conductscience.org/library/papers/31980749 | PubMed |
| 12 | 24346288 | Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24346288 | PubMed |
| 13 | 28796927 | Epithelial-to-mesenchymal transition contributes to invasion in squamous cell carcinomas originated from actinic keratosis through the differentiated pathway, whereas proliferation plays a more significant role in the classical pathway. | J Eur Acad Dermatol Venereol | 2018 | https://conductscience.org/library/papers/28796927 | PubMed |
| 14 | 22251204 | A systematic review of worldwide incidence of nonmelanoma skin cancer. | Br J Dermatol | 2012 | https://conductscience.org/library/papers/22251204 | PubMed |
| 15 | 26302407 | Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/26302407 | PubMed |
| 16 | 31461652 | Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant. | Cell Rep | 2019 | https://conductscience.org/library/papers/31461652 | PubMed |
| 17 | 28972076 | Secretory Autophagy in Cancer-Associated Fibroblasts Promotes Head and Neck Cancer Progression and Offers a Novel Therapeutic Target. | Cancer Res | 2017 | https://conductscience.org/library/papers/28972076 | PubMed |
| 18 | 26713601 | Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition. | Oncotarget | 2016 | https://conductscience.org/library/papers/26713601 | PubMed |
| 19 | 30231994 | Autophagy Controls CSL/RBPJκ Stability through a p62/SQSTM1-Dependent Mechanism. | Cell Rep | 2018 | https://conductscience.org/library/papers/30231994 | PubMed |
| 20 | 25928283 | Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. | JAMA Dermatol | 2015 | https://conductscience.org/library/papers/25928283 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42465026 | Unc-51 like kinase 3 induces reticulophagy by mediating the GLI1/CAMK2B signaling pathway to promote the malignant progression of prostate cancer. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42465026 | PubMed |
| 38339360 | TRPA1 Contributes to FGFR2c Signaling and to Its Oncogenic Outcomes in Pancreatic Ductal Adenocarcinoma-Derived Cell Lines. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38339360 | PubMed |
| 38248804 | A Panel of Potential Serum Markers Related to Angiogenesis, Antioxidant Defense and Hypoxia for Differentiating Cutaneous Squamous Cell Carcinomas from Actinic Keratoses. | J Pers Med | 2024 | https://conductscience.org/library/papers/38248804 | PubMed |
Genes26
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979155
GET https://conductscience.org/api/papers/v1/36979155/references?page=2